MedCity News
JANUARY 15, 2025
AI/big data haven’t solved healthcare’s challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency. The post Is Big Data the Cure-all for U.S. Healthcare? appeared first on MedCity News.
PharmaVoice
JANUARY 14, 2025
Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 13, 2025
Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae.The $7.22-per-share deal for 89.8% of Sage is a 30% premium on the company's share price on Friday and is estimated by Reuters to be worth around $442 million. Biogen has a longstanding alliance in place with Sage and co-markets Zurzuvae (zuranolone), which is FDA-approved for post-partum depression (PPD).
Healthcare Success
JANUARY 14, 2025
How can healthcare companies use marketing and branding to drive growth and reduce risks in preparation for mergers and acquisitions (M&A)? In this podcast, Victora Shepherd and I explore the critical role of brand integration throughout the M&A lifecycle, with a focus on private equity-backed healthcare companies. We discuss why marketing and brand strategy are often overlooked despite their ability to boost shareholder value by over 23% and improve M&A success rates by 42% [ Source
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
JANUARY 15, 2025
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharma Marketing Network
JANUARY 11, 2025
Table of Contents Sr# Headings 1 Introduction: The Power of SEO Campaigns in Pharma Marketing 2 Crafting an Effective SEO Strategy for Pharma Marketing 3 Leveraging Content Marketing in SEO Campaigns 4 Measuring Success and Optimizing SEO Campaigns Introduction: The Power of SEO Campaigns in Pharma Marketing In todays competitive digital landscape, SEO campaigns have become an indispensable tool for pharma marketing executives.
European Pharmaceutical Review
JANUARY 13, 2025
GSK has agreed to acquire the biopharmaceutical firm IDRx Inc, a company focused on development of precision therapies for gastrointestinal stromal tumours (GIST). The deal is valued up to $1.15 billion, which includes an upfront payment of $1 billion. IDRx Inc could receive a further $150 million, subject to achievement of future regulatory approvals.
MedCity News
JANUARY 17, 2025
With technology advancements specifically in the field of AI, there is a clear line of sight in making it mainstream. Here are some of the ways AI is helping to accelerate the adoption of PM. The post Precision Medicine: Becoming More Real With AI? appeared first on MedCity News.
PharmaVoice
JANUARY 16, 2025
The J.P. Morgan Healthcare Conference has been a focal point for M&A year after year, and after a quiet period, the deals are back on the table.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharma Marketing Network
JANUARY 11, 2025
Table of Contents Sr# Headings 1 Introduction: The Power of Pharmaceutical Advertising 2 Crafting Effective Pharmaceutical Advertising Campaigns 3 Navigating Regulations in Pharma Advertising 4 Leveraging Technology and Trends in Pharma Marketing Introduction: The Power of Pharmaceutical Advertising Pharmaceutical advertising plays a pivotal role in shaping healthcare decisions, bridging the gap between pharma companies, healthcare providers, and patients.
The Marketing Advantage
JANUARY 15, 2025
Given the limitations of some of the most common methods of evaluating a sales compensation plans effectiveness, how can life sciences companies achieve the robust examination necessary to ensure their plans are maximizing sales force motivation and, accordingly, maximizing sales? This blog presents a statistically based diagnostic system developed by The Marketing Advantage, Inc. to evaluate sales compensation plan effectiveness: SCORES.
MedCity News
JANUARY 14, 2025
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lillys CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected appeared first on MedCity News.
PharmaVoice
JANUARY 14, 2025
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
David Bagga
JANUARY 15, 2025
Break into Medical device Sales Navigating your career after Medical Sales College Medical sales college graduation means the beginning of an exciting journey ahead. A combination of skill, determination, and knowledge in the field will make a successful career from your medical sales training. The changeover from being a student to a medical sales representative […] The post Navigating your career after Medical Sales College appeared first on.
pharmaphorum
JANUARY 17, 2025
Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.
MedCity News
JANUARY 13, 2025
Johnson & Johnsons agreement to acquire Intra-Cellular Therapies brings Caplyta, which is projected to become a blockbuster seller across several neurological indications. In other M&A news, GSK and Eli Lilly each struck deals to fill their cancer drug pipelines. The post J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies appeared first on MedCity News.
PharmaVoice
JANUARY 13, 2025
The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the industry is still looking for more.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Scott Burrows
JANUARY 17, 2025
As the calendar turns and we step into a new year, its normal to feel a mix of emotionsexcitement, anticipation, and maybe even a little uncertainty. What will this year bring? Can I reach my goals? How will I handle the challenges that are bound to come my way? Through my journey, Ive discovered that no matter what lies ahead, approaching life with Vision, Mindset, and Grit is the key to staying grounded, focused, and resilient.
LEVO Health
JANUARY 15, 2025
As healthcare evolves, so does the technology that supports it. Telehealth and remote patient monitoring (RPM) are at the forefront of this transformation, allowing patients to receive care from the comfort of their homes. Marketing these advancements is essential for healthcare organizations to reach the growing number of patients seeking innovative solutions for their health needs.
MedCity News
JANUARY 15, 2025
Providence spun off its venture capital arm and renamed it Allumia Ventures. The newly independent venture capital firm also recently closed its third fund, in which Providence invested $150 million. Allumia is looking to grow the fund by inviting 3-5 other health systems to be limited partner investors. The post Providence Spun Out Its VC Arm So It Can Partner with Other Health Systems appeared first on MedCity News.
PharmaVoice
JANUARY 13, 2025
Companies are looking to new countries like Vietnam for manufacturing needs, but change comes at a cost.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTimes
JANUARY 13, 2025
Survey finds AI to enhance productivity and cut costs in the next 12 months
Pharmaceutical Technology
JANUARY 13, 2025
NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.
MedCity News
JANUARY 12, 2025
HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal though there are some concerns that smaller providers will struggle with the financial and operational burdens of compliance. The post HHS Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply appeared first on MedCity News.
PharmaVoice
JANUARY 17, 2025
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaTimes
JANUARY 15, 2025
Promising results from mouse study lead to expanded trials
LEVO Health
JANUARY 13, 2025
Artificial intelligence (AI) is rapidly revolutionizing the healthcare industry, reshaping the patient experience in the process. By leveraging AI in patient care, healthcare providers can improve patient outcomes, enhance efficiency, and reduce costs all while providing a more personalized and seamless patient experience. The AI healthcare market is projected to reach a value of $188 billion by 2030.
MedCity News
JANUARY 12, 2025
Gilead Sciences is acquiring LEO Pharmas oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gileads New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target appeared first on MedCity News.
Expert insights. Personalized for you.
306 
Let's personalize your content